查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1866561

臨床營養市場－2025-2030年預測

Clinical Nutrition Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 145 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

臨床營養市場預計將從 2025 年的 587.88 億美元成長到 2030 年的 893.38 億美元，複合年成長率為 8.73%。

臨床營養市場正經歷顯著成長，這主要得益於人們對使用專業產品解決營養缺乏和代謝紊亂問題的需求日益成長。這些產品包括維生素、蛋白質、礦物質和膳食補充劑，旨在維持營養平衡，尤其適用於慢性病患者。由於糖尿病和癌症等代謝紊亂的發病率不斷上升，以及營養不良和肥胖率的增加，預計該市場將從2023年起持續成長。全球人口老化，尤其是老年人更容易面臨代謝和營養的挑戰，也進一步推動了對臨床營養解決方案的需求。

臨床營養涵蓋多種產品，包括用於治療目的的腸外營養和經腸營養營養，這些產品需要獲得政府核准；以及無需監管部門批准的膳食補充劑（特殊醫學用途配方食品）。這些產品對於疾病管理至關重要，它們能夠為營養不良、代謝紊亂和其他健康問題提供個人化的營養支持。關鍵成長要素包括需要特殊營養介入的慢性疾病的增加，以及全球營養不良負擔的日益加重，尤其是在食物供應有限的地區。此外，老年人更容易出現營養缺乏也是推動市場擴張的因素，而臨床營養產品正是為了應對與老齡化相關的代謝挑戰而開發的。

然而，也存在一些局限性，例如對治療性營養產品嚴格的法規結構，這會延緩產品上市並增加合規成本。此外，消費者和醫療保健提供者對臨床營養益處的認知不足也阻礙了其廣泛應用。另一個挑戰是缺乏先進的分析技術來全面檢驗營養缺乏，這限制了個人化營養解決方案的準確性。

按地區分類，北美和歐洲佔據了相當大的市場佔有率，這主要得益於其先進的醫療保健體係以及人們對臨床營養在患者照護中作用的高度重視。亞太地區正崛起為重要的成長區域，這主要得益於醫療保健投資的增加和慢性病盛行率的上升。監管政策，尤其是在已開發市場，正在影響產品開發，而為確保安全性和有效性而製定的嚴格標準也增加了製造商的營運複雜性。

競爭情報涵蓋了貝朗主要企業（B. Braun Melsungen AG）、斯捷潘公司（Stepan Company）、雀巢健康科學（Nestle Health Science）、百特（Baxter）、雅培（Abbott）、Filament BioSolutions Inc.、紐崔斯（NUTRICIA）、費森尤斯卡比（Fresenius Kabi）、美贊臣營養品公司（Mead Johnson Nutrition Company）和佩里戈營養品公司（Perrigo Nutritionals）等主要企業。這些公司正致力於創新，開發先進的營養配方，並透過策略夥伴關係拓展市場佔有率。市場分析基於行業報告和相關人員的回饋，採用自下而上和自上而下的方法預測需求、供應和銷售趨勢。數據三角驗證確保了洞察的準確性，而圖表則有助於增強相關人員的理解。

受日益嚴峻的健康挑戰、人口老化以及對專業營養解決方案需求不斷成長的推動，臨床營養市場預計將在2023年至2025年間保持強勁成長。儘管監管障礙和認知差距依然存在，但持續創新和醫療保健覆蓋範圍的擴大將推動市場持續擴張。

本報告的主要優勢：

  • 深入分析：取得以客戶群、政府政策和社會經濟因素、消費者偏好、垂直產業和其他細分市場為重點的深入市場洞察，涵蓋主要地區和新興地區。
  • 競爭格局：了解主要企業採取的策略舉措，並了解透過正確的策略打入市場的潛力。
  • 市場促進因素與未來趨勢：探索動態因素和關鍵市場趨勢，以及它們將如何塑造未來的市場發展。
  • 可執行的建議：利用洞察力為策略決策提供訊息，從而在動態環境中開拓新的業務管道和收入來源。
  • 受眾範圍廣：對新興企業、研究機構、顧問公司、中小企業和大型企業都有益處且經濟高效。

它是用來做什麼的？

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範及其影響、新產品開發、競爭影響

分析範圍

  • 歷史資料（2022-2024 年）和預測資料（2025-2030 年）
  • 成長機會、挑戰、供應鏈前景、法規結構、客戶行為和趨勢分析
  • 競爭對手定位、策略和市場佔有率分析
  • 按業務板塊和地區（國家）分類的收入成長和預測分析
  • 公司概況（策略、產品、財務資訊、關鍵趨勢等）

目錄

第1章執行摘要

第2章市場概述

  • 市場概覽
  • 市場定義
  • 分析範圍
  • 市場區隔

第3章 商業情境

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 波特五力分析
  • 產業價值鏈分析
  • 政策和法規
  • 策略建議

第4章 技術展望

第5章 依產品類型分類的臨床營養市場

  • 介紹
  • 經腸營養
  • 腸外營養
  • 嬰兒營養
  • 特殊醫學食品
  • 補充

6. 依給藥途徑分類的臨床營養市場

  • 介紹
  • 口服
  • 腸內營養
  • 靜脈

7. 按治療領域分類的臨床營養市場

  • 介紹
  • 瘤
  • 代謝性疾病
  • 胃腸道疾病
  • 神經系統疾病
  • 慢性腎臟病
  • 兒童和新生兒
  • 加護治療和術後康復
  • 其他

第8章：按使用者類型分類的臨床營養市場

  • 介紹
  • 兒童
  • 成人
  • 老年人

9. 按最終用戶分類的臨床營養市場

  • 介紹
  • 醫院和診所
  • 居家醫療
  • 長期照護機構
  • 專科門診

第10章：按地區分類的臨床營養市場

  • 介紹
  • 北美洲
    • 依產品類型
    • 透過行政途徑
    • 按治療區域
    • 依使用者類型
    • 最終用戶
    • 按國家/地區
      • 美國
      • 加拿大
      • 墨西哥
  • 南美洲
    • 依產品類型
    • 透過行政途徑
    • 按治療區域
    • 依使用者類型
    • 最終用戶
    • 按國家/地區
      • 巴西
      • 阿根廷
      • 其他
  • 歐洲
    • 依產品類型
    • 透過行政途徑
    • 按治療區域
    • 依使用者類型
    • 最終用戶
    • 按國家/地區
      • 英國
      • 德國
      • 法國
      • 義大利
      • 其他
  • 中東和非洲
    • 依產品類型
    • 透過行政途徑
    • 按治療區域
    • 依使用者類型
    • 最終用戶
    • 按國家/地區
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 其他
  • 亞太地區
    • 依產品類型
    • 透過行政途徑
    • 按治療區域
    • 依使用者類型
    • 最終用戶
    • 按國家/地區
      • 日本
      • 中國
      • 印度
      • 韓國
      • 台灣
      • 其他

第11章 競爭格局與分析

  • 主要企業和策略分析
  • 市佔率分析
  • 企業合併、協議、商業合作
  • 競爭對手儀錶板

第12章：公司簡介

  • B. Braun Melsungen AG
  • Stepan Company
  • Nestle Health Science
  • Baxter International Inc.
  • Abbott
  • Filament BioSolutions Inc.
  • Danone SA
  • Fresenius Kabi AG
  • Mead Johnson Nutrition Company（Reckitt Benckiser Group Plc）
  • Perrigo Nutritionals
  • Pfizer
  • Dsm-Firmenich
  • Ajinomoto

第13章 分析方法

簡介目錄
Product Code: KSI061612085

The Clinical Nutrition Market will surge from USD 58.788 billion in 2025 to USD 89.338 billion by 2030, registering a 8.73% CAGR.

The clinical nutrition market is experiencing significant growth, driven by the increasing need to address nutritional deficiencies and metabolic disorders through specialized products. These products, including vitamins, proteins, minerals, and dietary supplements, are designed to maintain nutritional balance in patients, particularly those with chronic conditions. Since 2023, the market has been propelled by rising incidences of metabolic disorders such as diabetes and cancer, alongside growing malnutrition and obesity rates. The aging global population, particularly susceptible to metabolic and nutritional challenges, further fuels demand for clinical nutrition solutions.

Clinical nutrition encompasses a range of products, including parenteral and enteral nutrition, which require government approval due to their therapeutic applications, and medical foods used for nutritional support, which do not need regulatory clearance. These products are critical in managing conditions like malnutrition, metabolic disorders, and other health challenges by providing tailored nutritional support. Key growth drivers include the increasing prevalence of chronic diseases, which necessitate specialized nutritional interventions, and the rising global burden of malnutrition, particularly in regions with limited access to adequate diets. The geriatric population's vulnerability to nutritional deficiencies also drives market expansion, as clinical nutrition products address age-related metabolic challenges.

However, the market faces restraints, including stringent regulatory frameworks governing therapeutic nutrition products, which can delay product launches and increase compliance costs. Additionally, limited awareness of clinical nutrition's benefits among consumers and healthcare providers hinders adoption. The lack of advanced analytical technologies to fully validate nutritional deficiencies also poses challenges, as it limits the precision of tailored nutrition solutions.

Geographically, North America and Europe hold significant market shares, driven by advanced healthcare systems and high awareness of clinical nutrition's role in patient care. Asia-Pacific is emerging as a key growth region, fueled by rising healthcare investments and increasing chronic disease prevalence. Regulatory policies, particularly in developed markets, shape product development, with stringent standards ensuring safety and efficacy but also increasing operational complexities for manufacturers.

Competitive intelligence highlights major players such as B. Braun Melsungen AG, Stepan Company, Nestle Health Science, Baxter, Abbott, Filament BioSolutions Inc., NUTRICIA, Fresenius Kabi, Mead Johnson Nutrition Company, and Perrigo Nutritionals. These companies are investing in innovation to develop advanced nutritional formulations and expand their market presence through strategic partnerships. Market analysis, derived from industry reports and stakeholder inputs, employs bottom-up and top-down approaches to forecast demand, supply, and sales trends. Data triangulation ensures accurate insights, with charts and graphs enhancing stakeholder understanding.

From 2023 to 2025, the clinical nutrition market is poised for robust growth, driven by rising health challenges, an aging population, and increasing demand for specialized nutritional solutions. Regulatory hurdles and awareness gaps remain challenges, but ongoing innovations and expanding healthcare access position the market for sustained expansion.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation

By Product Type

  • Enteral Nutrition
  • Parenteral Nutrition
  • Infant Nutrition
  • Medical Foods
  • Supplements

By Route of Administration

  • Oral
  • Enteral
  • Parental

By Therapeutic Area

  • Oncology
  • Metabolic Diseases
  • Gastrointestinal (GI) Diseases
  • Neurological Disorders
  • Chronic Kidney Disease
  • Pediatric and Neonatal
  • Critical Care & Surgery Recovery
  • Others

By User Type

  • Pediatric
  • Adult
  • Geriatric

By End-User

  • Hospitals & Clinics
  • Homecare Settings
  • Long-term Care Facilities
  • Outpatient Specialty Centers

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Others
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. CLINICAL NUTRITION MARKET BY PRODUCT TYPE

  • 5.1. Introduction
  • 5.2. Enteral Nutrition
  • 5.3. Parenteral Nutrition
  • 5.4. Infant Nutrition
  • 5.5. Medical Foods
  • 5.6. Supplements

6. CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION

  • 6.1. Introduction
  • 6.2. Oral
  • 6.3. Enteral
  • 6.4. Parental

7. CLINICAL NUTRITION MARKET BY THERAPEUTIC AREA

  • 7.1. Introduction
  • 7.2. Oncology
  • 7.3. Metabolic Diseases
  • 7.4. Gastrointestinal (Gi) Diseases
  • 7.5. Neurological Disorders
  • 7.6. Chronic Kidney Disease
  • 7.7. Pediatric and Neonatal
  • 7.8. Critical Care & Surgery Recovery
  • 7.9. Others

8. CLINICAL NUTRITION MARKET BY USER TYPE

  • 8.1. Introduction
  • 8.2. Pediatric
  • 8.3. Adult
  • 8.4. Geriatric

9. CLINICAL NUTRITION MARKET BY END-USER

  • 9.1. Introduction
  • 9.2. Hospitals & Clinics
  • 9.3. Homecare Settings
  • 9.4. Long-term Care Facilities
  • 9.5. Outpatient Specialty Centers

10. CLINICAL NUTRITION MARKET BY GEOGRAPHY

  • 10.1. Introduction
  • 10.2. North America
    • 10.2.1. By Product Type
    • 10.2.2. By Route of Administration
    • 10.2.3. By Therapeutic Area
    • 10.2.4. By User Type
    • 10.2.5. By End-User
    • 10.2.6. By Country
      • 10.2.6.1. United States
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. South America
    • 10.3.1. By Product Type
    • 10.3.2. By Route of Administration
    • 10.3.3. By Therapeutic Area
    • 10.3.4. By User Type
    • 10.3.5. By End-User
    • 10.3.6. By Country
      • 10.3.6.1. Brazil
      • 10.3.6.2. Argentina
      • 10.3.6.3. Others
  • 10.4. Europe
    • 10.4.1. By Product Type
    • 10.4.2. By Route of Administration
    • 10.4.3. By Therapeutic Area
    • 10.4.4. By User Type
    • 10.4.5. By End-User
    • 10.4.6. By Country
      • 10.4.6.1. United Kingdom
      • 10.4.6.2. Germany
      • 10.4.6.3. France
      • 10.4.6.4. Italy
      • 10.4.6.5. Others
  • 10.5. Middle East & Africa
    • 10.5.1. By Product Type
    • 10.5.2. By Route of Administration
    • 10.5.3. By Therapeutic Area
    • 10.5.4. By User Type
    • 10.5.5. By End-User
    • 10.5.6. By Country
      • 10.5.6.1. Saudi Arabia
      • 10.5.6.2. UAE
      • 10.5.6.3. Others
  • 10.6. Asia Pacific
    • 10.6.1. By Product Type
    • 10.6.2. By Route of Administration
    • 10.6.3. By Therapeutic Area
    • 10.6.4. By User Type
    • 10.6.5. By End-User
    • 10.6.6. By Country
      • 10.6.6.1. Japan
      • 10.6.6.2. China
      • 10.6.6.3. India
      • 10.6.6.4. South Korea
      • 10.6.6.5. Taiwan
      • 10.6.6.6. Others

11. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 11.1. Major Players and Strategy Analysis
  • 11.2. Market Share Analysis
  • 11.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 11.4. Competitive Dashboard

12. COMPANY PROFILES

  • 12.1. B. Braun Melsungen AG
  • 12.2. Stepan Company
  • 12.3. Nestle Health Science
  • 12.4. Baxter International Inc.
  • 12.5. Abbott
  • 12.6. Filament BioSolutions Inc.
  • 12.7. Danone S.A.
  • 12.8. Fresenius Kabi AG
  • 12.9. Mead Johnson Nutrition Company (Reckitt Benckiser Group Plc)
  • 12.10. Perrigo Nutritionals
  • 12.11. Pfizer
  • 12.12. Dsm-Firmenich
  • 12.13. Ajinomoto

13. RESEARCH METHODOLOGY